The use of remdesivir outside of clinical trials during the COVID-19 pandemic

With a scientific background from filoviruses, paramyxoviruses, SARS-CoV, and MERS-CoV, remdesivir entered into the COVID-19 battle to become one of the favorable therapeutic candidates with potential antiviral activity in the treatment of this disease. Globally, remdesivir was accessed and investig...

Descripción completa

Detalles Bibliográficos
Autores principales: Halimi, Vesa, Daci, Armond, Ridova, Nevenka, Panovska-Stavridis, Irina, Stevanovic, Milena, Filipce, Venko, Dimovski, Aleksandar, Grozdanova, Aleksandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7503054/
https://www.ncbi.nlm.nih.gov/pubmed/32968487
http://dx.doi.org/10.1186/s40545-020-00258-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7503054/
https://www.ncbi.nlm.nih.gov/pubmed/32968487
http://dx.doi.org/10.1186/s40545-020-00258-8

Ejemplares similares